|Mode of transmission||Faecal–oral route or by ingestion of pharyngeal secretions.|
|Incubation period||Paralytic disease usually 7–14 days, with a reported range of 3–35 days.|
|Period of communicability||Most infectious in the days immediately before and after the onset of any symptoms. |
Transmission is possible as long as the virus is shed (can be years in the immune compromised).
|Global burden of disease||Endemic in Afghanistan, Nigeria and Pakistan. Outbreaks are still frequent (see www.polioeradication.org/Dataandmonitoring.aspx).|
|Funded vaccines||As inactivated polio vaccine (IPV), in combination with other antigens, or on its own: |
|Funded vaccine indications and schedule||Usual childhood schedule: |
For (re-)vaccination of eligible patients.
|Vaccine efficacy/effectiveness||Greater than 90 percent.|
|Precautions||Non-immune pregnant women may be immunised if they are travelling to a region where polio is endemic.|